RxDoctor Payments Data

Joshua Ouellette

Podiatry · West Haven, CTNPI 1760944136

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,188 of the $1,749 with a category attached, or 67.9%. 12 manufacturers reported payments, led by Stryker at 49.5% of the total. Reporting peaked in 2022 at $1,183 and has fallen 81.4% since, to $220 in 2025. Among podiatry clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,749in general payments, 2019–2025

Across 24 payments — averaging $72.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$867
  • Treace Medical Concepts, Inc.$220
  • Convatec Inc.$121
  • Hydrofera LLC$109
  • Orthofix Medical, Inc.$89
  • Smith+Nephew$74
  • plus $270 from 6 others

What the payments were for

  • Travel & lodging$56132%
  • Food & beverage$1,18868%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,749 in reported general payments places this provider in the 95th percentile of 26 podiatry providers in Connecticut.

See all podiatry providers in Connecticut

Medicare billing

Part B allowed, 2024
$140,938
Medicare patients
609
Services billed
1,571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole21$750
Ciclopirox11$329
Ammonium Lactate11$325
Terbinafine Hcl27$176
Cephalexin26$131
Mupirocin18$114
Prednisone13$29
Meloxicam12$11

Paid to pharmacies, not to this prescriber.

Other podiatry in West Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →